Phase I Study of Medical Food for the Dietary Management of Metastatic Pancreatic Cancer (NEAAR)
Summary
The purpose of this phase I study is to evaluate the safety and feasibility of NEAAR medical food in combination with gemcitabine and nab-paclitaxel in patients with pancreatic adenocarcinoma.
General Information
NCT#: NCT05078775
Study ID: NEAAR-001
Trial Phase: Phase I
Trial Sponsor: Faeth Therapeutics
Therapies Used in This Trial: Nab-paclitaxel, Gemcitabine, (NEAAR) Medical Food